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582 Abstracts February 2015ﬂap vs intramural hematoma (IMH). Demographic and disease-related vari-
ables were analyzed.
Results: Among 419 new cases of ATAD, we identiﬁed 16 patients
(3.8%) with previous known TBAD. Presence of ﬂap vs IMH could be
determined in 403 of 419 cases (96%). IMH was more common in pa-
tients with previous TBAD (56% vs 13%; P < .001). Previous thoracic
(six of 16 [38%]; P < .001) and abdominal aortic surgery (four of 16
[25%]; P ¼ .004) was also more common. There were two cases each
of open and endovascular repair of the descending thoracic aorta (Fig)
and two cases of open thoracoabdominal aortic repair. On multivariate
regression analysis, IMH and previous aortic surgery were associated
with new ATAD (P < .004). In-hospital mortality after ATAD repair in
TBAD patients occurred in one of 16 (6%).
Conclusions: Patients with IMH of the descending thoracic aorta
may develop new dissection in the ascending aorta. Not surprisingly, in pa-
tients with TBAD and new ATAD, there was an association with previous
aortic surgery. Surveillance of the ascending aorta is mandatory in all pa-
tients with TBAD.Fig. A new type A dissection in a patient initially treated with thoracic
endovascular aortic repair (TEVAR) for type B dissection.Author Disclosures: S. S. Leake: None; H. K. Sandhu: None; C. C.
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Objectives: Venous thoracic outlet syndrome (VTOS) most
commonly is treated by transaxillary, supraclavicular, or paraclavicular ap-
proaches based on surgeon preference. However, we have adopted an infra-
clavicular approach to VTOS because the surgical pathology is in the
anterior costoclavicular space. We hypothesize that this approach for
thoracic outlet decompression provides excellent access to the costoclavicu-
lar space and the axillosubclavian veins for safe and effective treatment of pa-
tients with an acute presentation of VTOS.
Methods: We retrospectively reviewed all consecutive patients who un-
derwent infraclavicular thoracic outlet decompression for an acute presentation
of VTOS from July 2005 to February 2014 by a single surgeon. Acute presen-
tation was deﬁned as <14 days between the onset of symptoms and catheter-
directedthrombolysis (CDT).Demographics, primary andsecondary subclavian
vein patency, perioperative outcomes, and reinterventions were recorded.
Results: Thirty patients (60% male) underwent an infraclavicular
approach for treatment of VTOS. Average age was 33 years. All patients un-
derwent CDT and subsequent infraclavicular ﬁrst rib resection and intrao-
perative venography, which was technically successful in all patients.
Intraoperative subclavian vein angioplasty was performed in 70%. Median
postoperative length of stay was 2 days (range, 2-6 days), blood loss was
75 mL (range, 20-200 mL), and operative time was 117 minutes (range,
76-166 minutes). Median follow-up was 78 days (range, 2-483 days). Ultra-
sound imaging at follow-up was performed in 24 of 30 (80%), with all pa-
tients having patent subclavian veins at last follow-up. Reinterventions
included two cases for rethrombosis and one case of hemothorax. There
were no complications of brachial plexus or phrenic nerve injury. All patients
at last follow-up were symptom free and subclavian veins were patent.Conclusions: An infraclavicular approach is a safe and effective treat-
ment for acute VTOS. It provides excellent access to the costoclavicular
space for ﬁrst rib resection and subclavian venolysis, while at the same
time minimizes the risk of brachial plexus and phrenic nerve injury.
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Objectives: The effects of concomitant endovascular interventions on
multiple infrapopliteal vessels are not well known, and the long-term
sequelae of such procedures have not been reported.
Methods: From 2004 to 2014, 673 patients underwent an infrapo-
pliteal endovascular intervention for tissue loss (77%), rest pain (13%),
stenosis of a previously treated vessel (5%), acute limb ischemia (3%),
or claudication (2%). Data collected included renal artery stenosis
(RAS) events (revascularization, major amputation, or stenosis [>3.5
step-up by duplex]) and wound healing. Patients without an initial indi-
cation of critical limb ischemia (CLI) were excluded. Patients were char-
acterized by single-vessel infrapopliteal interventions and multiple-vessel
infrapopliteal interventions. Worsened Rutherford class between index
procedure and failure was also noted.
Results: Of the 673 patients, 596 underwent an infrapopliteal endovas-
cular intervention for CLI: 85% for tissue loss and 15% for rest pain. During a
single procedure, 533 (89%) patients underwent a single-vessel intervention,
and 63 (11%) underwent a multiple-vessel intervention. Patients undergoing
a single-vessel intervention hadmore commonly experienced a prior ipsilateral
endovascular procedure (17% vs 10%; P¼ .04), whereas patients undergoing a
multiple-vessel interventionmore often suffered from diabetes (78% vs 89%; P
¼ .03) andweremore often discharged to a rehabilitation facility (33% vs 41%;
P¼ .04). Survival analysis revealed no difference in the proportion of patients
experiencing a restenosis (P ¼ .11). A Cox regression model illustrated that
long-term outcomes do not differ between patients undergoing a multiple-
vessel intervention vs those undergoing a single-vessel intervention. Among
the 596 patients, a RAS event occurred in 284 limbs (48%), and there was
no signiﬁcant difference in the rate of RAS events between single-vessel and
multiple-vessel infrapopliteal interventions (48% vs 49%; P ¼ .84; Fig). The
amputation rate also did not signiﬁcantly differ between the two groups
(14% vs 16%; P ¼ .71). In both groups, 8% of RAS patients presented with
a worse ischemia class compared with their initial symptoms.
Conclusions: Our data suggest that multiple-vessel intervention does
not improve outcomes compared with single-vessel intervention after any
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